Daily moves, business research, and the context that matters.
The June-ended quarter of fiscal twenty twenty-six brought year-over-year revenue growth and better operating profitability. The challenge is separating that progress from non-operating income and understanding the demands of reinvestment.
The fourth quarter of fiscal twenty twenty-six showed better results than the same fiscal quarter of the prior year, but product-level drivers remain unclear.
Higher sales came with better operating profitability, but the consolidated results leave important questions about the sources and staying power of earnings.
Revenue and operating profitability improved against the same fiscal quarter of the prior year, but cash generation did not follow the same pattern.
The aircraft engine specialist reported more revenue and operating profit than in the matching prior-year fiscal quarter, but a softer margin makes operating discipline the key question.
The June-ended fiscal quarter brought stronger revenue and a return to operating profit against the same fiscal quarter of the prior year. A substantial net loss shows why the rebuilding effort still needs scrutiny.
Revenue and earnings advanced against the same fiscal quarter of the prior year, but the consolidated results leave the sources of that strength unresolved.
Sales and operating profitability improved against the same fiscal quarter of the prior year. The next question is what powered that progress.
Sales and operating profitability strengthened against the prior-year fiscal quarter, but less operating cash arrived despite higher earnings.
The cancer and vaccine maker generated positive operating cash, but its reported loss keeps attention on the economics behind the revenue.
The opening quarter of fiscal twenty twenty-seven brought stronger sales and operating profitability, but the cash demands of expansion remain a central business issue.
The July-ending quarter paired expanding revenue with positive operating income, but the net loss shows why platform reach and earnings quality need separate scrutiny.
The June fiscal quarter brought higher reported revenue but weaker operating profitability, putting the spotlight on how much P&G earns from its household essentials.
The second fiscal quarter of twenty twenty-six paired expanding revenue with stronger operating economics, but consolidated results leave important questions about the underlying demand.
A healthier operating margin is the encouraging result. Modest sales growth and uneven earnings keep attention on contract economics rather than the size of the healthcare platform.
Reported sales and profitability advanced against the same fiscal quarter of the prior year, while cash generation supported substantial equipment spending.
Results for the quarter ended 2026-06-30 show how revenue and credit risk affected earnings. The dated assessment on 2026-10-08 was wait at a reference price of $15.66.
Results for the quarter ended 2026-06-30 bring the business drivers and cash after investment into focus. The dated assessment on 2026-10-08 was wait at a reference price of $167.6.
Results for the quarter ended 2026-06-30 bring the business drivers and cash after investment into focus. Quarterly free cash flow was $9.09 bn. The dated assessment on 2026-10-08 was wait at a reference price of $472.2.
Results for the quarter ended 2026-06-30 bring the business drivers and cash after investment into focus. Quarterly free cash flow was -$0.69 bn. The dated assessment on 2026-10-08 was wait at a reference price of $60.65.
41–60 of 87 articlesPage 3 of 5
